Skip to content

Author

Wolfram Mayr

We have 1 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Longitudinal SARS-CoV-2 mRNA vaccine immunogenicity in inflammatory bowel disease in relation to anti-TNF therapy and age: a prospective cohort study.

BACKGROUND Patients with inflammatory bowel disease (IBD) on immunomodulatory therapy may respond less well to vaccination. We followed humoral and cellular responses to SARS-CoV-2 vaccination over 12 months. METHODS In this single-centre, prospective cohort study, adults with IBD received mRNA vaccine under the Aust...

Wolfram Mayr, Astrid I. Knell, A. Boehm et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.